Re:Theranos Ran Tests Despite Quality Problems
by ghshephard on Tuesday March 08, 2016 @02:02AM
(#11243913)
See https://news.ycombinator.com/item?id=11243904 above as to why the cost issue is a risk assessment / return analysis. In certain scenarios in which potential harm is high from an incorrect diagnosis, it's worth the cost to perform the test completely independently.
[ Parent
| on HN ]
There are no comments on this comment yet.